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Abstract
Human small cell lung cancers (SCLC) and cell lines derived
therefrom are phenotypically heterogeneous concerning neuro-
endocrine differentiation. Unlike most SCLC tumors and cell
lines that express poorly differentiated neuroendocrine pheno-
types, the SCLC cell line DMS 53 exhibits mature endocrine
differentiation features, including unusually high expression of
the gene for the peptide hormone, calcitonin (CT). We now
report that introduction of the viral Harvey ras (v-ras") onco-
gene into DMS 53 cells via retroviral infection, with resultant
constitutive expression, results in increased features of neuro-
endocrine differentiation. 7-10 d after infection the cells dem-
onstrated altered morphology, increased CT secretion, in-
creased CT gene expression, markedly diminished cellular pro-
liferation, and nearly abolished methylcellulose cloning
efficiency. This response of DMS 53 cells to v-rasH is unlike
the tumor progression effects we have previously observed in
other SCLC lines. Significantly, the differentiation response
that follows expression of the virally introduced v-rasH onco-
gene in DMS 53 cells is similar to that of neoplastic neuroen-
docrine cell lines derived from adrenal pheochromocytes and
thyroid C cells. The effects of constitutive v-rasH expression in
DMS 53 SCLC cells and other neuroendocrine cell lines sug-
gest an important role for rasH or related genes in neuroendo-
crine differentiation.
Introduction
Human small cell lung cancer (SCLC)' in cell culture exhibits
a range of phenotypes that may reflect both the differentiation
state ofthe bronchial cell of origin and ongoing progression of
events during tumor development. Cultures of SCLC hence
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MTC, medullary thyroid carcinoma cells; SCLC, small cell lung
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represent important human cell systems to explore molecular
events that regulate phenotypic alterations ofnormal and neo-
plastic epithelial cells.
Most SCLC lines, termed classic SCLC, have properties
similar to tumors in patients, including high expression of
markers typical of early neuroendocrine cell development and
a modest degree of endocrine differentiation (1, 2). A signifi-
cant number of other SCLC lines, characterized as biochemi-
cal variant or morphologic variant SCLC, have decreased
levels of these same endocrine differentiation markers, in-
creased proliferative indices, amplification of the c-myc gene,
and growth patterns and biochemical markers more typical of
non-SCLC (1, 2). The SCLC line DMS 53 is unique because it
demonstrates more differentiated endocrine features than typi-
cally found in classic and variant cells. These include high
levels of specific small polypeptide hormones in addition to
expression of early neuroendocrine markers (3, 4).
We have been interested in the genetic and biochemical
signals that mediate differentiation of these cell phenotypes in
the SCLC lineage and recently have shown that when the viral
Harvey ras oncogene (v-ras1) is expressed via retroviral infec-
tion in variant SCLC, these cells acquire features typical of
large cell lung cancer cell lines including adherent growth,
increased growth rate, augmented cloning efficiency, resis-
tance to the polyamine analogue a-difluoromethylornithine,
and further loss of neuroendocrine markers (5). However,
when classic SCLC cells similarly express high levels of v-ra?',
their growth characteristics, drug sensitivity, and neuroendo-
crine markers were not affected (5).
SCLC cells with more mature endocrine features were not
initially studied, and hence pose an interesting question with
regard to differentiation responses within the SCLC cell lin-
eages. In nonpulmonary neuroendocrine neoplastic cell lines
from well-defined endocrine tissues, increasing ras gene ex-
pression or microinjection ofits p21 protein product results in
acquisition of a more differentiated state (6-9). Such results
1 2 3 Figure 1. Northern blot
hybridization of 8 ug of
total cytoplasmic RNA
A v-rosH - -7.5 kb isolated from unin-
v~rasH kb fected DMS 53 SCLC
(lane 1), 1504A helper
-444 kb virus-infected DMS 53SCLC (lane 2), and Ha-
MSV-infected DMS 53
SCLC (lane 3) probed
B ~-actin * * -2.3kb with (A) an Sst I-Pst I
fragment (730 bp) con-
taining only the v-rasH p21 coding region (Oncor) and (B) ,B-actin.
Note high expression of v-ras' in Ha-MSV infected DMS 53 cells
(lane 3). ,B-Actin signals demonstrate equivalent loading in each lane.
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Figure 2. Photomicrographs of uninfected DMS 53 cells (top) and Ha-MSV DMS 53 cells 7 d after infection (bottom). Note morphological al-
teration from a flat monolayer in uninfected cells (top) to rounded, larger cells growing as mounds of cells (bottom). No morphologic changes
were noted in DMS 53 SCLC cells infected with 1504A helper virus alone. X200.
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Figure 3. Growth curves of
12.0 Ha-MSV infected and unin-
fected DMS 53 SCLC cells.
0.0-O ~ o/A t --Cell number was determined
after trypsinization using an
x/,' automated cell counter
_ 6.0 - (Coulter Electronics Inc.).
aft' Each point represents the
4.0 mean (±SD) of triplicate wells
in three separate experiments.
2.0 No alterations in growth were
found in DMS 53 cells in-
3 5 7 9 I'm fected with 1 504A helper virus1 3 5 7 9 1I
Day alone.
have been obtained with rat PC 12 pheochromocytoma cells
(6-8) and, in our laboratory, with human medullary thyroid
carcinoma cells (MTC) (9). SCLC line DMS 53 has phenotypic
similarity to MTC in that expression of the calcitonin (CT)
gene and resultant CT hormone secretion is extremely high (3,
4). We speculated that the effects of introduction and consti-
tutive expression of v-ras' in DMS 53 cells might then differ
from the effects of v-rasH expression in other SCLC lines, and
might instead result in acquisition ofdifferentiation-associated
features, such as increased CT gene expression and decreased
growth. We now demonstrate that v-rasH expression will dif-
ferentiate DMS 53 SCLC cells. Our findings emphasize further
that mutated ras genes can supply critical functions for alter-
ing cell phenotypes in human lung cancer, and that the re-
sponses obtained depend on the initial differentiation status of
the cell. These data support an important role for ras or other
genes with similar functions in regulating endocrine cell dif-
ferentiation and show that ras gene expression in specific types
of cultured tumor cells with pronounced neuroendocrine
characteristics can cause a decrease in phenotypic features as-
sociated with malignancy.
Methods
Cell culture and viral infection. Cells ofa well-characterized culture line
of human SCLC, DMS 53 (3, 4), were grown at 370C in Waymouth's
media supplemented with 16% vol/vol of heat-inactivated fetal bovine
serum (Gibco Laboratories, Grand Island, NY), 2 mM glutamine, 100
U penicillin, and 100 mg streptomycin sulfate/ml in a humidified CO2
incubator. The v-rasH gene was introduced into DMS 53 cells using
our previously described conditions (5, 9-1 1). Briefly, NIH 3T3 cells,
infected with, Harvey murine sarcoma virus (Ha-MSV) and 1504A
amphotropic murine leukemia helper virus, as well as NIH 3T3 cells
infected with 1504A amphotropic murine leukemia helper virus alone,
were grown in DME (Gibco Laboratories) supplemented with 9%
(vol/vol) heat-inactivated fetal bovine serum. For viral infection, DMS
53 cells were exposed to conditioned medium from the infected NIH
3T3 cells which contained high titers of Ha-MSV and 1504A helper
virus or supernatant containing 1504A helper virus alone. Efficiency of
infection of DMS 53 SCLC cells was increased by use of Polybrene
(Sigma Chemical Co., St. Louis, MO) at 1.0 ug/ml.
Growth studies. 10 d after viral infection the cells were harvested by
trypsinization and seeded in 25-cm2 polystyrene flasks at a density of
2.0 X I05 cells/ml. Cell numbers were determined using an automatic
cell counter (Coulter Electronics Inc., Hialeah, FL) and periodically
confirmed by hemocytometer counts.
Cloning efficiency. DMS 53 cells infected with Ha-MSV and unin-
fected DMS 53 controls were suspended at a density of 10,000 cells/ml
in 1.8% methylcellulose in growth medium. The methylcellulose/cell
suspension was layered over a 3% agar base. Colonies were evaluated
and scored at day 10. Cloning efficiency was calculated as the number
of colonies per plate divided by the number of cells suspended. The
data reported are results of three independent experiments, each con-
taining quintuplicate samples.
Secretion ofcalcitonin. Supernatant from Ha-MSV-infected or un-
infected DMS 53 cells was centrifuged (1,500 g, 3 min) and the con-
centration ofCT in the supernatants was determined by RIA (12) and
normalized to cell number. Culture media not exposed to cells had no
detectable CT levels.
cDNA probes. CT (pTT1062) and CT gene-related peptide (CGRP)
(pTT42) cDNA probes have been described (13). pTT1062 contains
only human CT-specific sequences (exon 4). Neither CGRP-specific
sequences (exons 5-6), nor sequences common to both CT and CGRP
(exons 1-3), are found in this probe. pTT83 contains a Pvu II-Pst I
restriction fragment from pTT42 which contains only CGRP-specific
sequences including 17 bp of exon 5 and all of exon 6 of the CT
gene (13).
Recombinant plasmids containing human f3-actin sequences were
provided by D. Cleveland (Johns Hopkins University School ofMedi-
cine, Baltimore, MD). An Sst-Pst I fragment (730 bp) containing only
the v-rasH gene p2 I coding region was obtained from Oncor (Gaith-
ersburg, MD). All probes were labeled with [32P]dCTP by nick transla-
tion to a sp act of " 5 X 108 cpm/,ug ofDNA.
RNA hybridization. Cytoplasmic RNA was extracted by NP-40
lysis in the presence of vanadyl ribonucleoside complex as previously
described (12, 14). 8 ,ug oftotal or 4 ,g ofpoly A' selected cytoplasmic
RNA for Northern'blot hybridization analysis was electrophoresed in a
6% formaldehyde/1.2% agarose gel and transferred to nitrocellulose.
Filters were hybridized in 5X SSPE (IX SSPE = 150mM NaCl, 10mM
Na phosphate, 1 mM EDTA), 10% formamide, 1% SDS, 60 mg/ml
polyethylene glycol 8,000, 5 mg/ml powdered milk, and 200 gg/ml
sonicated salmon sperm DNA for 16 h at 42°C. After hybridization
filters received a final wash with 0.1X standard saline citrate, pH
7.0/0.1% SDS at 650C for 30 min. For autoradiography, films were
exposed for 24-36 h at -700C. Hybridizations and quantitation of
signal for CT and fl-actin RNAs by densitometry were performed as
described (12, 13).
Results
Efficient viral infection and resultant constitutive expression
of v-rasH occurred after infection of DMS 53 cells with Ha-
MSV. Northern blots of total cytoplasmic RNA (8 ;&g) hybrid-
ized with a 730-bp Sst I-Pst I fragment containing only the
v-rasH coding region showed levels of v-rasH mRNA that were
103-fold greater than the levels of endogenous c-rasH tran-
scripts detected in uninfected control cells when probed with
the above viral probe (Fig. 1) or with a probe for the human
c-ras" gene (data not shown). Transcripts homologous to the
v-rasH coding region probe, under our hybridization condi-
tions, were not detected in uninfected control cells nor those
infected with helper virus alone.
Within 7 d after infection with Ha-MSV, DMS 53 cells
developed marked morphological changes. Cells became more
rounded and larger, with increased cytoplasm to nucleus ratio,
and had a less pyknotic nuclear pattern with prominent nu-
cleoli. While DMS 53 cells normally grow as a flat confluent
monolayer, after Ha-MSV infection they grew as rounded
mounds of cells (Fig. 2). No morphologic alterations were ob-
served after infection with the amphotropic helper virus alone.
Growth ofDMS 53 was markedly reduced after infection
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Figure 4. Photomicrographs of methylcellulose/agar plates of uninfected DMS 53 SCLC cells (A) and Ha-MSV-infected DMS 53 SCLC cells
(B). Note the presence of multiple large clones of cells in DMS 53 SCLC (A). In contrast, Ha-MSV-infected DMS 53 SCLC (B) shows no clones
present. DMS 53 SCLC cells infected with Ha-MSV removed from the methylcellulose suspensions remained viable as assessed by trypan blue
dye exclusion. Clones were counted at day 10.
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with Ha-MSV. Cell doubling times were increased from 36 to
70 h (Fig. 3). Decreased growth was accompanied by marked
reduction in cloning efficiency. Cloning efficiency in methyl-
cellulose-agar was reduced from 8.2 to 0.2% after induction
of the v-rasH expression (Fig. 4). DMS 53 cells expressing v-
rasH remained viable as assessed by trypan blue staining after
their removal from the methylcellulose suspensions.
Decreased growth often accompanies cell differentiation.
Our previous studies of human MTC (9) demonstrated that
v-rasH infection resulted in diminished growth and induction
ofa program ofdifferentiation that included a marked increase
in expression of the neuroendocrine peptide hormone gene,
CT. DMS 53 SCLC cells, which also produce high basal levels
of CT, might be expected to increase CT production in re-
sponse to differentiation. Fig. 5 shows that increased CT se-
cretion occurs after infection with Ha-MSV. Consistent with
this product increase, the Ha-MSV-infected cells had increased
expression of CT mRNA (Fig. 6). It is interesting that the
increase involves only one of the two major mRNA species
generated by alternative processing of the CT gene. One of
these species, CT mRNA, contains exons 1, 2, 3, and 4 and is
elevated threefold. However, the other major mRNA species
from the CT gene, which encodes CGRP, and which is derived
from exons 1, 2, 3, 5, and 6 (13, 15), did not increase after
expression of the virally introduced v-rasH oncogene (Fig. 6).
Discussion
In many cell types, ras gene overexpression or mutation is
associated with neoplastic transformation or progression (5,
16-23). However, previous studies in two well-defined neuro-
endocrine tumor cell lines, rat pheochromocytoma cell line PC
12 (6-8) and human MTC (9), demonstrated that expression
of an exogenously introduced ras gene or gene product can
induce features of neuroendocrine differentiation. We now
show that neoplastic endocrine cells that arise from the com-
plex background of the bronchial epithelium, and which are
putative progenitors of the cancer SCLC, differentiate in a
fashion similar to human MTC and PC 12 after expression of
the virally introduced v-rasH oncogene. We observed acquisi-
tion of differentiation-associated features which include a de-
crease of such tumorigenic properties as the ability of the cells
to clone, and a reduced cell growth fraction. In contrast, no
phenotypic alterations were observed in DMS 53 SCLC cells
800 *--*DMS53RAS
_ DMS 53
Figure 5. CT secretion of
DMS 53 SCLC cells and
600 / " DMS 53 SCLC cells in-fected with Ha-MSV. 7 d
after viral infection the
cells were trypsinized and
E seeded at 2.0 X 105 cells/
g 400 well. CT content in the
s ,/ media was measured by
RIA at indicated time
points. No differences in
200 ,' /t CT secretion were seen
with 1504A helper virus
alone. Each point repre-
sents mean (±SD) of tripli-
3 5 7 1l cate wells for three separate
Day experiments.
1 2
A CT
-
Ikb
B CGRP en: -I kb
C 3-octin a.4111 -2.3 kb
Figure 6. (A) Hybridization of
8 ,g ofDMS 53 SCLC control
and Ha-MSV-infected DMS
53 SCLC total cytoplasmic
RNA with the CT-specific
exon 4 probe pTT1062. Note
increased CT mRNA in DMS
53 SCLC infected with Ha-
MSV (lane 2) compared with
uninfected controls (lane 1).
(B) Hybridization of 4 ,g of
poly A' selected DMS 53 SCLC control and Ha-MSV-infected DMS
53 SCLC mRNA with CGRP-specific pTT83 probe. No alteration in
CGRP expression is observed. (C) fl-Actin controls indicate equiva-
lent loading in each lane.
solely infected with 1504A amphotrophic helper virus alone.
These data suggest that acquisition of differentiation-asso-
ciated features in response to ras expression may be specific for
cells of distinct neuroendocrine phenotypes.
Our results in cell culture appear to correlate with recent
observations in vivo regarding ras gene expression and neuro-
endocrine cell differentiation. For example, high levels of the
ras gene protein product p21 have been demonstrated by im-
munohistochemistry in differentiated neural or neuroendo-
crine tissue (24). Moreover, increased expression of rasH pro-
tein product p21 predicts favorable prognoses in patients with
neuroblastoma (25). These results suggest that ras or related
genes may have an important role in maintenance of neuroen-
docrine phenotypes.
The data obtained from the DMS 53 SCLC cell line are
especially significant when viewed in the context of our pre-
vious work with v-rasH and SCLC (5). SCLC cell lines with
partially developed neuroendocrine features, termed classic
SCLC, demonstrated no phenotypic alterations of growth,
morphology, biochemical markers, or drug sensitivity after the
virally introduced v-rasH gene was expressed. Biochemical
variant SCLC acquired non-SCLC features and demonstrated
features oftumor progression (5). Thus, the response to v-rasH
expression seen in SCLC cells appears to be dependent on the
phenotypic context of the recipient cell.
The molecular mechanisms by which the ras gene influ-
ences endocrine cell differentiation and the behavior of lung
cancer cells may relate to the functions of the ras gene prod-
ucts, which may mediate signal transduction events. Our data
with DMS 53 SCLC, which shares neuroendocrine features
with MTC and PC 12 cells, suggests that ras-mediated trans-
duction events may replace functions lost after transformation
of pulmonary endocrine cells. The differential phenotypic re-
sponses in SCLC lines after v-rasH expression may reflect the
different responses that normal bronchial epithelial cells may
exhibit in response to expression of ras or related genes in vivo
during cell renewal and differentiation. Elucidation of the spe-
cific genetic and biochemical events responsible for the differ-
ential responses to expression of virally introduced v-rasH in
different SCLC cell lines should provide important informa-
tion regarding the mechanisms through which alterations of
genes such as rasH may promote or interfere with normal dif-
ferentiation processes. The model systems offered by cultured
human lung cancer cells with differential phenotypic responses
to the rasH gene provide unique means to pursue these ques-
tions.
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